References
- Raymond DP, et al. Preventing antimicrobial-resistant bacterial infections in surgical patients (CDC/SIS position paper). Surgical Infections 2002; 3(4): 375–385
- Ibrahim, et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Grit Care Med 2001; 29: 1109–1155
- Dermeson, et al. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pnetunonia. Am J Respir Grit Care Med 2001; 163: 1371–1375
- Singh, et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000; 162:505–511
- Chastre, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia. JAM A 2003; 290: 2588–2598
- Schentag, et al. Role for dual individualization with cefmenoxime. Am J Med 1984; 77: 43–50
- Schentag JJ. Antimicrobial management strategies for Gram-positive bacterial resistance in the intensive care unit. Crit Care Med 2001; 29: N100–N107
- Van den Berghe, et al. Intensive insulin therapy in critically ill patients NEJM2001; 345: 1359–1367
- Eggimann, et al. Impact of a prevention strategy at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000; 355: 1864–1868
- Zack. et al. Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med 2002; 30:2407–2412
- Paul, et al. Beta- lactam monotherapy versus beta-lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ2004; 328:668–672
- Chamot, et al. Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother 2003; 47:2756–2774
- Raymond, et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med 2001; 29: 1101–1108
- Brown EM, Nathwani D. Antibiotic cycling or rotation: a systematic review of the evidence of efficacy. J Antimicrob Chemother 2005; 55: 6–9
- Paterson DL. “Collateral Damage” from cephalosporin or quinolones antibiotic therapy. Clin Infect Dis 2004; 38: S341–S345
- Trouillet, et al. Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistantversus piperacillin-susceptible organisms. Clin Infect Dis 2002; 34:1047–1054
- Paramythiotou, et al. Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care unitis: role of antibiotics with antipseudomonal activity. Clin Infect Dis 2004; 38: 670–677